In vitro Activity of Cefiderocol and Comparators against Carbapenem-Resistant Gram-Negative Pathogens from France and Belgium

• Hoofdauteurs: Saoussen Oueslati (Auteur), Pierre Bogaerts (Auteur), Laurent Dortet (Auteur), Sandrine Bernabeu (Auteur), Hend Ben Lakhal (Auteur), Christopher Longshaw (Auteur), Youri Glupczynski (Auteur), Thierry Naas (Auteur)
• Formaat: Boek
• Gepubliceerd in: MDPI AG, 2022-10-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Infections with carbapenem-resistant (CR) Gram-negative (GN) pathogens have increased in many countries worldwide, leaving only few therapeutic options. Cefiderocol (CFDC) is approved in Europe for the treatment of aerobic GN infections in adults with limited treatment options. This study evaluated...